• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成A、B血型免疫吸附剂的实际应用

Practical application of synthetic A and B blood group immunoadsorbents.

作者信息

Crawford G, Adatia A, Naylor D H, Moore B P

出版信息

Rev Fr Transfus Immunohematol. 1981 Jun;24(3):281-7. doi: 10.1016/s0338-4535(81)80207-3.

DOI:10.1016/s0338-4535(81)80207-3
PMID:7280452
Abstract

The effectiveness of synthetic blood group A and B immunoadsorbents in removing anti-A and anti-B from human sera was evaluated. The sera contained specific alloantibodies and were destined for use as diagnostic reagents. Both Synsorb-A(TM) and Synsorb-B(TM) removed all saline anti-A or anti-B activity from 20 sera tested. All trace of anti-A activity detectable by the indirect antiglobulin test was removed from only 20% of sera; anti-B with similar reactivity was removed from 66% of sera. Specific (wanted) alloantibody titres were reduced by synsorb-A in 60% of sera, but were unaffected by Synsorb-B. Despite these shortcomings, such immunoadsorbents are of value particularly when cells of appropriate phenotype are unavailable for absorptions.

摘要

评估了合成血型A和B免疫吸附剂从人血清中去除抗A和抗B的效果。这些血清含有特异性同种抗体,旨在用作诊断试剂。Synsorb - A(TM)和Synsorb - B(TM)都从20份测试血清中去除了所有盐水抗A或抗B活性。通过间接抗球蛋白试验可检测到的所有抗A活性痕迹仅从20%的血清中被去除;具有相似反应性的抗B从66%的血清中被去除。Synsorb - A使60%的血清中特异性(所需)同种抗体滴度降低,但Synsorb - B对其无影响。尽管存在这些缺点,但这种免疫吸附剂仍有价值,特别是在没有合适表型的细胞用于吸收时。

相似文献

1
Practical application of synthetic A and B blood group immunoadsorbents.合成A、B血型免疫吸附剂的实际应用
Rev Fr Transfus Immunohematol. 1981 Jun;24(3):281-7. doi: 10.1016/s0338-4535(81)80207-3.
2
Preparation and use of synthetic blood group specific immunoadsorbents.合成血型特异性免疫吸附剂的制备与应用
Behring Inst Mitt. 1988 Apr(82):94-103.
3
Noncellular immunoadsorbents for preparing typing sera that recognize high-frequency red cell antigens.用于制备识别高频红细胞抗原的分型血清的非细胞免疫吸附剂。
Transfusion. 1988 Nov-Dec;28(6):556-8. doi: 10.1046/j.1537-2995.1988.28689059030.x.
4
Flow rate dependence of in vitro removal of anti-A and anti-B antibodies by immunoadsorbents with synthetic oligosaccharides representing blood group substances.用代表血型物质的合成寡糖免疫吸附剂体外去除抗A和抗B抗体的流速依赖性
Int J Artif Organs. 1989 Dec;12(12):799-804.
5
Specific removal of anti-red cell blood group activity from anti-HLA lymphocytotoxic sera and purification of anti-A and anti-B antibodies with lymphocytotoxic activity.从抗人淋巴细胞抗原(HLA)淋巴细胞毒性血清中特异性去除抗红细胞血型活性,并纯化具有淋巴细胞毒性活性的抗A和抗B抗体。
Tissue Antigens. 1985 Aug;26(2):147-52. doi: 10.1111/j.1399-0039.1985.tb00948.x.
6
In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose.对一种新的连接有合成碳水化合物的琼脂糖ABO免疫吸附剂的体外评估。
Transpl Int. 2005 Jan;17(11):666-72. doi: 10.1007/s00147-004-0775-7. Epub 2004 Nov 17.
7
Immunoadsorbents with synthetic oligosaccharide hapten representing blood group A substances.具有代表A血型物质的合成寡糖半抗原的免疫吸附剂。
Bioconjug Chem. 1991 Jan-Feb;2(1):32-7. doi: 10.1021/bc00007a006.
8
Comparison of the absorption of allo-anti-B by red cells and by a synthetic immunoadsorbent using the autoanalyzer.使用自动分析仪比较红细胞和合成免疫吸附剂对同种抗B的吸收情况。
Rev Fr Transfus Immunohematol. 1983 Dec;26(6):585-90. doi: 10.1016/s0338-4535(83)80073-7.
9
The use of cellulose carbonate-based immunoadsorbents in the isolation of minor allotypic components of rabbit immunoglobulin populations.基于碳酸纤维素的免疫吸附剂在兔免疫球蛋白群体次要同种异型成分分离中的应用。
J Immunol Methods. 1982;50(1):57-75. doi: 10.1016/0022-1759(82)90304-0.
10
[Use of quantitative immunofluorescence for determining the adsorption capacity of magnetic immunosorbents].
Zh Mikrobiol Epidemiol Immunobiol. 1988 May(5):56-8.

引用本文的文献

1
A murine monoclonal antibody against blood group H type-1 and -2 structures.一种针对血型H1型和H2型结构的鼠单克隆抗体。
Immunology. 1983 Oct;50(2):215-21.